304 related articles for article (PubMed ID: 25586691)
1. Intrinsic cancer subtypes--next steps into personalized medicine.
Santos C; Sanz-Pamplona R; Nadal E; Grasselli J; Pernas S; Dienstmann R; Moreno V; Tabernero J; Salazar R
Cell Oncol (Dordr); 2015 Feb; 38(1):3-16. PubMed ID: 25586691
[TBL] [Abstract][Full Text] [Related]
2. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
3. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
4. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Syn NL; Yong WP; Goh BC; Lee SC
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine: In need of guidance and surveillance.
Lin JZ; Long JY; Wang AQ; Zheng Y; Zhao HT
World J Gastroenterol; 2017 Jul; 23(28):5045-5050. PubMed ID: 28811702
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy in cancer.
Tsimberidou AM
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
[TBL] [Abstract][Full Text] [Related]
7. Cancer classification in the genomic era: five contemporary problems.
Song Q; Merajver SD; Li JZ
Hum Genomics; 2015 Oct; 9():27. PubMed ID: 26481255
[TBL] [Abstract][Full Text] [Related]
8. Successes and limitations of targeted cancer therapy in breast cancer.
Curigliano G; Criscitiello C
Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
[TBL] [Abstract][Full Text] [Related]
9. Cancer genomics guide clinical practice in personalized medicine.
Lehmann-Che J; Poirot B; Boyer JC; Evrard A
Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
[TBL] [Abstract][Full Text] [Related]
10. The Master Protocol Concept.
Redman MW; Allegra CJ
Semin Oncol; 2015 Oct; 42(5):724-30. PubMed ID: 26433553
[TBL] [Abstract][Full Text] [Related]
11. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
[TBL] [Abstract][Full Text] [Related]
12. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
Do K; O'Sullivan Coyne G; Chen AP
Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
[TBL] [Abstract][Full Text] [Related]
13. From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy.
Palma S; Zwenger AO; Croce MV; Abba MC; Lacunza E
Clin Colorectal Cancer; 2016 Jun; 15(2):104-15. PubMed ID: 26777471
[TBL] [Abstract][Full Text] [Related]
14. Histological tumor typing in the age of molecular profiling.
Klauschen F; Heim D; Stenzinger A
Pathol Res Pract; 2015 Dec; 211(12):897-900. PubMed ID: 26589872
[TBL] [Abstract][Full Text] [Related]
15. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
[TBL] [Abstract][Full Text] [Related]
16. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
17. Personalised cancer medicine.
Jackson SE; Chester JD
Int J Cancer; 2015 Jul; 137(2):262-6. PubMed ID: 24789362
[TBL] [Abstract][Full Text] [Related]
18. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.
Ortiz MV; Kobos R; Walsh M; Slotkin EK; Roberts S; Berger MF; Hameed M; Solit D; Ladanyi M; Shukla N; Kentsis A
Pediatr Blood Cancer; 2016 Aug; 63(8):1368-74. PubMed ID: 27082517
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.
Morello G; Cavallaro S
Future Med Chem; 2015; 7(10):1335-59. PubMed ID: 26144267
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
